Renal function in heart transplant patients after switch to combined mammalian target of rapamycin inhibitor and calcineurin inhibitor therapy

BACKGROUND: A calcineurin inhibitor (CNI)-based immunosuppression combined with mammalian target of rapamycin inhibitors (mTORs) seems to be attractive in patients after heart transplantation (HTX) in special clinical situations, for example, in patients with adverse drug effects of prior immunosupp...

Descripción completa

Detalles Bibliográficos
Autores principales: Helmschrott, Matthias, Rivinius, Rasmus, Bruckner, Thomas, Katus, Hugo A, Doesch, Andreas O
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5472407/
https://www.ncbi.nlm.nih.gov/pubmed/28652705
http://dx.doi.org/10.2147/DDDT.S135503

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5472407/
https://www.ncbi.nlm.nih.gov/pubmed/28652705
http://dx.doi.org/10.2147/DDDT.S135503

Ejemplares similares